Rethinking WHO guidance: Review of evidence for misoprostol use in the prevention of postpartum haemorrhage

Journal of the Royal Society of Medicine

Volumn 105, Issue 8, 2012, Pages 336-347

  Chu, Christina s ^a   Brhlikova, Petra ^a   Pollock, Allyson m ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MISOPROSTOL; OXYTOCIC AGENT; ERGOMETRINE; METHYLERGOMETRINE MALEATE; PLACEBO;

CHILL; DRUG EFFICACY; DRUG FEVER; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; LABOR STAGE 3; NAUSEA; PATIENT REFERRAL; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHIVERING; SIDE EFFECT; SWEAT; VOMITING; DRUG EFFECT; EVIDENCE BASED MEDICINE; FEMALE; PATIENT SAFETY; PRACTICE GUIDELINE; PREGNANCY; TREATMENT OUTCOME; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; ARTICLE; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; HIGH RISK PATIENT; LABOR; LOWEST INCOME GROUP; MEDICAL DECISION MAKING; MEDICAL LITERATURE; OUTCOME ASSESSMENT; SYSTEMATIC REVIEW;

EVIDENCE-BASED MEDICINE; FEMALE; GREAT BRITAIN; HUMANS; LABOR STAGE, THIRD; MISOPROSTOL; OXYTOCICS; PATIENT SAFETY; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84865451618     PISSN: 01410768     EISSN: 17581095     Source Type: Journal    
DOI: 10.1258/jrsm.2012.120044     Document Type: Review

References (32)

1. Hogan M, Foreman K, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-23
2. Hill K, Thomas K, Abou Zahr C, et al. Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet 2007;370:1311-9
3. WHO. The World Health Report 2005. Make every mother and child count 2005. See http://www.who.int/whr/2005/whr2005_en.pdf (last accessed 3 July 2012)
4. Brabin B, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001;131:604S–14S
5. WHO. Worldwide Prevalence of Anaemia 1993-2005: WHO Global Database on Anaemia. Geneva: World Health Organisation, 2008
6. WHO. WHO Recommendations for the Prevention of Postpartum Haemorrhage. Geneva: WHO, 2007
7. Hogerzeil H, Walker G, De Goeje M. Stability of Injectable Oxytocics in Tropical Climates: Results of Field Surveys and Simulation Studies on Ergometrine, Methylergometrine and Oxytocin–EDM Research Series No. 008. Geneva: World Health Organisation, 1993
8. WHO. WHO statement regarding the use of misoprostol for postpartum haemorrhage prevention and treatment. 2009. See http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/misoprostol/en/ (last accessed 3 July 2012)
9. ICM, FIGO. Prevention and Treatment of Post-partum Haemorrhage. New Advances for Low Resource Settings. Joint Statement. Hague and London: ICM and FIGO, 2006
10. Gulmezoglu A, Forna F, Villar J, Hofmeyr G. Prostaglandins for preventing postpartum harmorrhage. Cochrane Database Syst Rev 2007 Issue 3, Art No.: CD000494
11. Walraven G, Blum J, Dampha Y, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG 2005;112:1277-83
12. Høj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005;331:723
13. Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006;368:1248-53
14. Potts M, Prata N, El Refaey H, et al. Empowering women to control post-partum haemorrhage. Lancet 2010;375:459-60
15. Mobeen N, Durocher J, Zuberi N, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 2011;118:353-61
16. Hofmeyr GJ, Gülmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 2009;87:666-77
17. Patted SS, Goudar SS, Naik VA, et al. Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India. J Matern Fetal Neonatal Med 2009;22:24-28
18. Prata N, Gessessew A, Abraha AK, et al. Prevention of Postpartum Hemorrhage: Options for Home Births in Rural Ethiopia. Afr J Reprod Health 2009;13:87-95
19. Chandhiok N, Dhillon B, Datey S, Mathur A, Saxena N. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynaecol Obstet 2006;92:170-5
20. Schorn MN. Measurement of blood loss: review of the literature. J Midwifery Womens Health 2010;55:20-27
21. de Groot AN, van Roosmalen J, van Dongen PW, Borm GF. A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstet Gynecol Scand 1996;75:464-8
22. Mathai M, Gülmezoglu AM, Hill S. Saving womens lives: evidence-based recommendations for the prevention of postpartum haemorrhage. Bull World Health Organ 2007;85:322-3
23. Goudar S, Chakraborty H, Edlavitch S, et al. Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol. J Matern Fetal Neonatal Med 2008;21:559-64
24. Begley CM, Gyte GML, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2011, Issue 11. Art. No.: CD007412
25. Walraven G, Wanyonyi S, Stones W. Management of post-partum hemorrhage in low-income countries. Best Pract Res Clin Obstet Gynaecol 2008;22:1013-23
26. Fernandez MM, Coeytaux F, de Leon RG, Harrison DL. Assessing the global availability of misoprostol. Int J Gynaecol Obstet 2009;105:180-6
27. Sherris J, Bingham A, Burns M, Girvin S, Westley E, Gomez P. Misoprostol use in developing countries: results from a multicountry study. Int J Gynaecol Obstet 2005;88:76-81
28. Holden M. Misoprostol: Strategies, Successes & Challenges. 2009. See http://www.pphprevention.org/files/VSIHoldenPOPPHI20091120FINAL.pdf (last accessed 1 August 2012)
29. Starrs A, Winikoff B. Misoprostol for postpartum hemorrhage: Moving from evidence to practice. International Journal of Gynecology and Obstetrics 2012;116:1-3
30. Wagner M. Born in the USA: how a broken maternity system must be fixed to put mothers and infants first. University of California Press: Berkeley 2006
31. WHO. Unedited report of the 18th expert committee on the selection and use of essential medicines. Technical Report Series. Accra, Ghana World Health Organization March 2011
32. Annual Health Sector Performance Report Financial Year 2009/2010. Republic of Uganda. See http://www.health.go.ug/docs/AHSPR09.pdf (last accessed 1 August 2012)